TrialNeuro-oncology2018

Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapy.

Timothy F Cloughesy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.